Fig. 9From: Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapyChemical structures of dual VEGFR–HDAC inhibitors 64 and 65 and their inhibitory activities against VEGFR2 and HDACBack to article page